# REDS-IV-P - CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) -  SARS-CoV-2/COVID-19 STUDIES

> **NIH NIH N01** · VITALANT · 2020 · $4,748,941

## Abstract

This project will focus on key blood safety issues with COVID-19 and further our understanding of SARS-CoV-2 natural history and pathogenesis.

## Key facts

- **NIH application ID:** 10149201
- **Project number:** 75N92019D00033-P00002-759201900074-1
- **Recipient organization:** VITALANT
- **Principal Investigator:** MICHAEL Paul BUSCH
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $4,748,941
- **Award type:** —
- **Project period:** 2019-04-01 → 2021-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10149201

## Citation

> US National Institutes of Health, RePORTER application 10149201, REDS-IV-P - CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) -  SARS-CoV-2/COVID-19 STUDIES (75N92019D00033-P00002-759201900074-1). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10149201. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*